## ARE: Alexandria Real Estate Equities - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 2.5% below STRENGTH zone (3.0-6.0%); PEG 844.20 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($43.55)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 1, Bearish: 9)

**1. Pomerantz LLP Highlights Class Action Filing Against Alexandria Real Estate Equities, Inc. – ARE**
- Source: WLNS 6 News | 20251216T110747 | Bearish | Relevance: 100%
- Pomerantz LLP has filed a class action lawsuit against Alexandria Real Estate Equities, Inc. (NYSE:ARE) after the company reported disappointing financial results for Q3 2025, including a significant real estate impairment charge. The lawsuit alleges securities fraud or other unlawful business practices, and investors who purchased ARE securities during the Class Period have until January 26, 2026, to seek appointment as Lead Plaintiff. The stock price fell by over 19% following the announcement.

**2. Shareholders who lost money in shares of Alexandria Real Estate Equities, Inc. (NYSE: ARE) Should Contact Wolf Haldenstein Immediately**
- Source: GlobeNewswire | 20251215T162117 | Bearish | Relevance: 100%
- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors who purchased Alexandria Real Estate Equities (NYSE: ARE) shares between January 27, 2025, and October 27, 2025, that a federal securities class action has been filed. The lawsuit follows disappointing Q3 2025 financial results, including a cut to FFO guidance and a significant real estate impairment charge, which caused a substantial drop in stock price. Investors have until January 26, 2026, to seek appointment as lead plaintiff.

**3. ARE UPCOMING DEADLINE: Alexandria Real Estate Equities, Inc. Impairment Charge Triggers Securities Class Action – Contact BFA Law before January 26 Deadline**
- Source: GlobeNewswire | 20251215T130758 | Bearish | Relevance: 100%
- A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and its executives for securities fraud following a significant stock drop. The lawsuit claims the company misrepresented its leasing volume and development pipeline, leading to a $323.9 million real estate impairment charge in 3Q 2025 and a stock decline of over 19%. Investors are encouraged to contact Bleichmar Fonti & Auld LLP before the January 26, 2026 deadline to potentially lead the case.

**4. ARE UPCOMING DEADLINE: Alexandria Real Estate Equities, Inc. Impairment Charge Triggers Securities Class Action – Contact BFA Law before January 26 Deadline**
- Source: GlobeNewswire | 20251215T130732 | Bearish | Relevance: 100%
- A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) alleging securities fraud after the company announced an unexpected impairment charge and cut its guidance, causing a significant stock drop. Investors have until January 26, 2026, to seek appointment as lead plaintiff in the lawsuit. The complaint suggests the company misrepresented its occupancy rates and leasing activity, leading to a $323.9 million real estate impairment charge.

**5. ARE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Alexandria Real Estate Equities, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!**
- Source: CBS 17 | 20251215T120754 | Bearish | Relevance: 100%
- Bronstein, Gewirtz and Grossman, LLC has filed a class action lawsuit against Alexandria Real Estate Equities, Inc. (NYSE:ARE) on behalf of investors who purchased securities between January 27, 2025, and October 27, 2025. The lawsuit alleges that Alexandria made false and misleading statements regarding the leasing value and true state of its Long Island City property, particularly concerning its Megacampus™ strategy. Investors have until January 26, 2026, to request to be appointed as lead plaintiff in the case.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 6)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Citigroup | $52 | $61 | -15% |
| 2025-12-04 | Evercore ISI Gr | $64 | $72 | -11% |
| 2025-12-04 | BMO Capital | $60 | $67 | -10% |
| 2025-12-04 | Baird | $67 | $73 | -8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Citigroup | main | Neutral |
| 2025-12-04 | Evercore ISI Gr | main | Outperform |
| 2025-12-04 | BMO Capital | main | Outperform |
| 2025-12-04 | Baird | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 8 ($0.14M) |
| Sells | 3 ($0.15M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Vanguard Group Inc: 14.9% (-1.1%)
- Blackrock Inc.: 10.0% (-10.7%)
- State Street Corpora: 6.5% (+3.7%)
- Apg Asset Management: 3.9% (0.0%)
- JPMORGAN CHASE & CO: 3.3% (+34.1%)

### Key Risks

1. Valuation risk: PEG 844.2x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 36.9% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +12.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 844.20 signals overvaluation risk, limited margin of safety. Revenue declining -6% YoY, concerning. Analyst sentiment negative (6 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.2B |
| Beta | 1.33 |
| 52W Range | $44.10 - $105.14 |
| Short Interest | 4.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 844.20 |
| Forward P/E | 245.6 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from -9.7% to 2.5% (+12.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.5pp (needs >3.0% for momentum thesis). MRS_5 at 4.0% confirms short-term momentum alignment. Below SMA200 (0.63x), long-term trend not supportive. OFD pattern: +DBL (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.46% (CS: 55) | Neutral |
| RSI_14 | 36.4 | Neutral |
| MACD Histogram | 0.43 | Bullish |
| vs SMA20 | 0.962x | Below |
| vs SMA50 | 0.795x | Below |
| vs SMA200 | 0.631x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $47.41
- **Stop Loss:** $43.55 (8.1% risk)
- **Target:** $51.27 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 259
- **Position Value:** $12,279.19
- **Portfolio %:** 12.28%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-01-26 (Est: $0.42)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.39 | $0.50 | +28.2% |
| 2025Q2 | $0.63 | $0.48 | -24.0% |
| 2025Q1 | $0.60 | $0.51 | -15.5% |
| 2024Q4 | $0.90 | $0.69 | -23.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*